Novelion Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States0-1 Employees
Novelion Therapeutics is a Boston-based biotechnology company focused on developing therapies for rare diseases. Its diversified portfolio is carried through its indirect subsidiary, Aegerion Pharmaceuticals, which markets MYALEPT and Juxtapid. The company is also pursuing zuretinol acetate as a potential treatment for inherited retinal disease caused by mutations in RPE65 or LRAT genes. Its work targets patients with rare genetic conditions and the clinicians who treat them, as well as partners through licensing arrangements that extend access. A notable development in its recent history is Recordati's licensing agreement to commercialize Juxtapid in Japan, illustrating external collaborations to broaden the reach of its therapies.